CDKN2A and Huntington disease: By introducing a second cutoff of 20% for the exclusion of homozygous loss and continuing to sequence cases within the 6–20% gray zone, we find virtually perfect concordance between pathologist-scored p16 expression and CDKN2A HD status, without any false positives or false negatives.